Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Lung
Published in: Lung 3/2006

01-06-2006

An Update on Interventional Lung Assist Devices and Their Role in Acute Respiratory Distress Syndrome

Authors: Marc-Alexander von Mach, Joachim Kaes, Babatunde Omogbehin, Ingo Sagoschen, Jascha Wiechelt, Kristina Kaiser, Oliver Sauer, Ludwig Sacha Weilemann

Published in: Lung | Issue 3/2006

Login to get access

Abstract

In recent years, pumpless arteriovenous systems for extracorporeal gas exchange have become a new therapeutic option for the treatment of patients suffering from acute respiratory failure. Experiences with the pumpless extracorporeal membrane lung in animal experiments and in patients with adult respiratory distress syndrome published in the current literature are reviewed. In addition this article presents a case of varicella pneumonia with persistent hypoxemia and hypercapnia under mechanical ventilation that showed a significant improvement with treatment with a pumpless extracorporeal lung assist using an arteriovenous shunt for eight days. The patient made a complete recovery. This is the first report of a patient with a life-threatening varicella pneumonia successfully treated with pumpless extracorporeal lung assist device. This review provides an update on interventional lung assist devices and a critical discussion of their advantages and limitations.
Literature
1.
Amato MB, Barbas CS, Medeiros DM, et al. (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338:347–354PubMedCrossRef
2.
Awad JA, Deslauriers J, Major D, Guojin L, Martin L (1991) Prolonged pumpless arteriovenous perfusion for carbon dioxide extraction. Ann Thorac Surg 51:534–540PubMedCrossRef
3.
Bein T, Kuhr LP, Metz C, et al. (2002) ARDS and severe brain injury. Therapeutic strategies in conflict. Anaesthesist 51:552–556PubMedCrossRef
4.
Bein T, Prasser C, Philipp A, et al. (2004) Pumpless extracorporeal lung assist using arteriovenous shunt in severe ARDS. Experience with 30 cases. Anaesthesist 53:813–819PubMed
5.
Bein T, Scherer MN, Philipp A, Weber F, Woertgen C (2005) Pumpless extracorporeal lung assist (Pecla) in patients with acute respiratory distress syndrome and severe brain injury. J Trauma 58:1294–1297PubMedCrossRef
6.
Bensberg R, Dembinski R, Kopp R, Kuhlen R (2005) Artificial lung and extracorporeal gas exchange. Panminerva Med 47:11–17PubMed
7.
Brederlau J, Anetseder M, Wagner R, et al. (2004) Pumpless extracorporeal lung assist in severe blunt chest trauma. J Cardiothorac Vase Anesth 18:777–779CrossRef
8.
Brederlau J, Anetseder M, Mullenbach R, et al. (2005) The present role of interventional lung assist (ILA) in critical care medicine. Anasthesiol Intensivmed Notfallmed Schmerzther 40:74–78PubMedCrossRef
9.
Brunston RL Jr, Tao W, Bidani A, et al. (1997) Prolonged hemodynamic stability during arteriovenous carbon dioxide removal for severe respiratory failure. J Thorac Cardiovasc Surg 114:1107–1114PubMedCrossRef
10.
Brunston RL Jr, Zwischenberger JB, Tao W, et al. (1997) Total arteriovenous CO2 removal: simplifying extracorporeal support for respiratory failure. Ann Thorac Surg 64:1599–1604PubMedCrossRef
11.
David M, Heinrichs W (2004) High-frequency oscillatory ventilation and an interventional lung assist device to treat hypoxaemia and hypercapnia. Br J Anaesth 93:582–586PubMedCrossRef
12.
De Somer F, van Belleghem Y, Foubert L, et al. (1999) Feasibility of a pumpless extracorporeal respiratory assist device. J Heart Lung Transplant 18:1014–1017PubMedCrossRef
13.
Dschietzig T, Laule M, Melzer C, Baumann G (2005) Long-term treatment of severe respiratory failure with an extracorporeal lung assist — a case report. Intensivmed 42:365–370
14.
Frangides CY, Pneumatikos I (2004) Varicella-zoster virus pneumonia in adults: report of 14 cases and review of the literature. Eur J Intern Med 15:364–370PubMedCrossRef
15.
Gattinoni L, Kolobow T, Agostoni A, et al. (1979) Clinical application of low frequency positive pressure ventilation with extracorporeal CO2 removal (LFPPV-ECCO2R) in treatment of adult respiratory distress syndrome (ARDS). Int J Artif Organs 2:282–283PubMed
16.
Gattinoni L, Pesenti A, Mascheroni D, et al. (1986) Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256:881–886PubMedCrossRef
17.
Jayroe JB, Alpard SK, Wang D, et al. (2001) Hemodynamic stability during arteriovenous carbon dioxide removal for adult respiratory distress syndrome: a prospective randomized outcomes study in adult sheep. ASAIO J 47:211–214PubMedCrossRef
18.
Jayroe JB, Wang D, Deyo DJ, et al. (2003) The effect of augmented hemodynamics on blood flow during arteriovenous carbon dioxide removal. ASAIO J 49:30–34PubMedCrossRef
19.
Leiba A, Apter S, Leiba M, Thaler M, Grossman E (2004) Acute respiratory failure in a patient with sarcoidosis and immunodeficiency—an unusual presentation and a complicated course. Lung 182:73–77PubMedCrossRef
20.
Lewandowski K, Rossiant R, Pappert D, et al. (1997) High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Int Care Med 23:819–835CrossRef
21.
Liebold A, Reng CM, Philipp A, Pfeifer M, Birnbaum DE (2000) Pumpless extracorporeal lung assist—experience with the first 20 cases. Eur J Cardiothorac Surg 17:608–613PubMedCrossRef
22.
Liebold A, Philipp A, Kaiser M, et al. (2002) Pumpless extracorporeal lung assist using an arterio-venous shunt. Applications and limitations. Minerva Anestesiol 68:387–391PubMed
23.
Lynch WR, Montoya JP, Brant DO, et al. (2000) Hemodynamic effect of a low-resistance artificial lung in series with the native lungs of sheep. Ann Thorac Surg 69:351–356PubMedCrossRef
24.
Mer M, Richards GA (1998) Corticosteroids in life-threatening varicella pneumonia. Chest 114:426–431PubMed
25.
26.
Morris AH, Wallace CJ, Menlove RL, et al. ( 1994) Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149:295–305PubMed
27.
Murphy JA, Savage CM, Alpard SK, et al. (2001) Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal. Perfusion 16:460–468PubMed
28.
Reng M, Philipp A, Kaiser M, et al. (2000) Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet 356:219–220PubMedCrossRef
29.
Schinzel H, Berghoff K, Beuermann I, et al. (in press) Anticoagulation with low-molecular-weight heparin (dalteparin) in plasmapheresis therapy—initial experience. Transfusion (DOI: 10.1111/j.1537-2995.2006.00755.x) Published online
30.
Stride PJ, Campher MJ, Geary JM, Coulter C, Duhig EE (2004) Adult chickenpox complicated by fatal necrotising pneumonia. Med J Aust 181:160–161PubMed
31.
Suter M (1997) Therapeutic strategies leading to a better lung function in severe acute pulmonary failure. Intensivmed 34:462–465CrossRef
32.
Tao W, Brunston RL Jr, Bidani A, et al. (1997) Significant reduction in minute ventilation and peak inspiratory pressures with arteriovenous CO2 removal during severe respiratory failure. Crit Care Med 25:689–695PubMedCrossRef
33.
Wahba A, Philipp A, Behr R, Birnbaum DE (1998) Heparin-coated equipment reduces the risk of oxygenator failure. Ann Thorac Surg 65:1310–1312PubMedCrossRef
34.
Zapol WM, Snider MT, Hill JD, et al. (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242:2193–2196PubMedCrossRef
35.
Zwischenberger JB, Conrad SA, Alpard SK, Grier LR, Bidani A (1999) Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure. Ann Thorac Surg 68:181–187PubMedCrossRef
Metadata
Title
An Update on Interventional Lung Assist Devices and Their Role in Acute Respiratory Distress Syndrome
Authors
Marc-Alexander von Mach
Joachim Kaes
Babatunde Omogbehin
Ingo Sagoschen
Jascha Wiechelt
Kristina Kaiser
Oliver Sauer
Ludwig Sacha Weilemann
Publication date
01-06-2006
Publisher
Springer-Verlag
Published in
Lung / Issue 3/2006
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-005-2577-9

Other articles of this Issue 3/2006

Lung 3/2006 Go to the issue

OriginalPaper

Role of Pleural Fluid C-Reactive Protein Concentration in Discriminating Uncomplicated Parapneumonic Pleural Effusions from Complicated Parapneumonic Effusion and Empyema

OriginalPaper

Giant Cell Interstitial Pneumonia Associated with Nitrofurantoin

OriginalPaper

Does the Inclusion of Wheeze Detection as an Outcome Measure Affect the Interpretation of Methacholine Challenge Tests? A Study in Workers at Risk of Occupational Asthma

OriginalPaper

Tissue Doppler Evaluation of Tricuspid Annulus for Estimation of Pulmonary Artery Pressure in Patients with COPD

OriginalPaper

Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer

OriginalPaper

A Controlled Trial of the Effects of Leg Training on Breathing Pattern and Dynamic Hyperinflation in Severe COPD
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits